{"duration": 0.017710208892822266, "input_args": {"text": "'Medscape \\nExcerpts: \\nBALTIMORE \u2014 New findings from a large national claims database show the use of cholesterol-lowering statin drugs to be associated with an increased risk for Parkinson\u2019s disease (PD), contrary to previous research suggesting the drugs have a protective effect for PD. \\n\u201cWe identified 20,000 Parkinson\u2019s disease patients and looked at whether using statins was associated with a higher or lower risk, and we found people using statins have a higher risk of the disease, so this is the opposite of what has been hypothesized,\u201d senior author Xuemei Huang, MD, PhD, vice chair for research at Penn State College of Medicine, Hershey, Pennsylvania, told Medscape Medical News . \\nWhile high cholesterol has been shown to have a protective effect on the risk for PD, the role of statin use has been the subject of debate. Published on October 31, 2016'"}, "time": 1742562582.83967}